Read the latest updates on coronavirus from Harvard University. For SEAS specific-updates, please visit SEAS & FAS Division of Science: Coronavirus FAQs

Alumni News Brief

Brangwynne co-founds Nereid Therapeutics

Clifford P. Brangwynne, Ph.D. ’07, chairs scientific advisory board

Clifford Brangwynne

Life sciences venture firm Apple Tree Partners (ATP) has co-founded Nereid Therapeutics with leading biophysicist Clifford P. Brangwynne, Ph.D. ’07 (applied physics).

Nereid Therapeutics is dedicated to discovering new disease treatments by applying pioneering research and technologies in biomolecular condensates, and launches with a $50 million Series A funding commitment from ATP.

Brangwynne, Professor of Chemical and Biological Engineering at Princeton University, studies the fundamental principles underlying biological organization, with a particular interest in membrane-less organelles/condensates which form within living cells. He won a MacArthur Foundation “Genius Grant” in 2018.

Read more in this press release.

Press Contact

Adam Zewe | 617-496-5878 | azewe@seas.harvard.edu